Biofilms of mycobacterium abscessus complex can be sensitized to antibiotics by disaggregation and oxygenation
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Biofilms of mycobacterium abscessus complex can be sensitized to antibiotics by disaggregation and oxygenation. / Kolpen, Mette; Jensen, Peter Østrup; Qvist, Tavs; Kragh, Kasper Norskov; Ravnholt, Cecillie; Fritz, Blaine Gabriel; Johansen, Ulla Rydahl; Bjarnsholt, Thomas; Hoiby, Niels.
In: Antimicrobial Agents and Chemotherapy, Vol. 64, No. 2, e01212, 2020.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Biofilms of mycobacterium abscessus complex can be sensitized to antibiotics by disaggregation and oxygenation
AU - Kolpen, Mette
AU - Jensen, Peter Østrup
AU - Qvist, Tavs
AU - Kragh, Kasper Norskov
AU - Ravnholt, Cecillie
AU - Fritz, Blaine Gabriel
AU - Johansen, Ulla Rydahl
AU - Bjarnsholt, Thomas
AU - Hoiby, Niels
PY - 2020
Y1 - 2020
N2 - Pulmonary infection with the multidrug-resistant Mycobacterium abscessus complex (MABSC) is difficult to treat in individuals with cystic fibrosis (CF). MABSC grows as biofilm aggregates in CF patient lungs, which are known to have anaerobic niches. How aggregation and anoxic conditions affect antibiotic tolerance is not well understood. We sought to determine whether disaggregation and oxygen availability sensitize MABSC isolates to recommended antibiotics. We tested the susceptibilities of 33 isolates from 22 CF patients with MABSC infection and a reference strain to the following antibiotics: amikacin, azithromycin, cefoxitin, ciprofloxacin, clarithromycin, imipenem, kanamycin, linezolid, moxifloxacin, rifampin, tigecycline, and sulfamethoxazole-trimethoprim. Isolates were grown in Mueller-Hinton broth with and without the disaggregating detergent Tween 80 (5%). Time-kill curves at days 1 and 3 were generated for oxic and anoxic amikacin treatment in 4-fold dilutions ranging from 2 to 512mg liter1. Scanning electron microscopy was used to visualize the aggregation patterns, while confocal laser scanning microscopy and microrespirometry were used to visualize biofilm growth patterns. Disruption of MABSC aggregates increased susceptibility to amikacin, tigecycline, kanamycin, azithromycin, imipenem, cefoxitin, and clarithromycin (P<0.05, n29 to 31). Oxygenation enhanced the killing of disaggregated MABSC isolates by amikacin (P<0.05) by 1 to 6 log units when 2 to 512mg liter1 of amikacin was used. This study explains why current drug susceptibility testing results correlate poorly with treatment outcomes. The conditions achieved by oxic culturing of planktonic isolates in vitro do not resemble the hypoxic conditions in CF patient lungs. Biofilm disruption and increased O2 availability during antibiotic therapy may be new therapeutic strategies for chronic MABSC infection.
AB - Pulmonary infection with the multidrug-resistant Mycobacterium abscessus complex (MABSC) is difficult to treat in individuals with cystic fibrosis (CF). MABSC grows as biofilm aggregates in CF patient lungs, which are known to have anaerobic niches. How aggregation and anoxic conditions affect antibiotic tolerance is not well understood. We sought to determine whether disaggregation and oxygen availability sensitize MABSC isolates to recommended antibiotics. We tested the susceptibilities of 33 isolates from 22 CF patients with MABSC infection and a reference strain to the following antibiotics: amikacin, azithromycin, cefoxitin, ciprofloxacin, clarithromycin, imipenem, kanamycin, linezolid, moxifloxacin, rifampin, tigecycline, and sulfamethoxazole-trimethoprim. Isolates were grown in Mueller-Hinton broth with and without the disaggregating detergent Tween 80 (5%). Time-kill curves at days 1 and 3 were generated for oxic and anoxic amikacin treatment in 4-fold dilutions ranging from 2 to 512mg liter1. Scanning electron microscopy was used to visualize the aggregation patterns, while confocal laser scanning microscopy and microrespirometry were used to visualize biofilm growth patterns. Disruption of MABSC aggregates increased susceptibility to amikacin, tigecycline, kanamycin, azithromycin, imipenem, cefoxitin, and clarithromycin (P<0.05, n29 to 31). Oxygenation enhanced the killing of disaggregated MABSC isolates by amikacin (P<0.05) by 1 to 6 log units when 2 to 512mg liter1 of amikacin was used. This study explains why current drug susceptibility testing results correlate poorly with treatment outcomes. The conditions achieved by oxic culturing of planktonic isolates in vitro do not resemble the hypoxic conditions in CF patient lungs. Biofilm disruption and increased O2 availability during antibiotic therapy may be new therapeutic strategies for chronic MABSC infection.
KW - Antimicrobial resistance
KW - Biofilm
KW - Cystic fibrosis
KW - Mycobacterium abscessus complex
KW - Oxygenation
U2 - 10.1128/AAC.01212-19
DO - 10.1128/AAC.01212-19
M3 - Journal article
C2 - 31740557
AN - SCOPUS:85078567607
VL - 64
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
SN - 0066-4804
IS - 2
M1 - e01212
ER -
ID: 235775594